---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-065057"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T07:43:22.530993+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TuHURA amends Kineta merger; revises consideration, extends end date to June 30, 2025

## Summary
- First Amendment revises merger consideration: Initial Stock Consideration based on $16.5M less adjustments at $5.7528/share.
- Delayed Stock Consideration set at $6.5M less liabilities and working capital deficits, divided by share value and fully diluted shares.
- Cash Consideration base $12M, with credits for $5M exclusivity, $300K extension, $695K advances, loaned amount, and working capital adjustment.
- End Date extended to June 30, 2025; closing condition requires TuHURA to receive at least $20M from concurrent investment.
- CSO Dennis Yamashita terminated Dec 16, 2024; severance $145,833 over 5 months, COBRA 6 months, options vest on 65,597 shares.

## SEC filing metadata
- accession: 0000950170-25-065057
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000095017025065057/0000950170-25-065057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000095017025065057/hura-20250505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-065057
- JSON: https://secwatch.observer/filing/0000950170-25-065057.json
- Plain text: https://secwatch.observer/filing/0000950170-25-065057.txt

## Key facts
- Executive change
  Dennis Yamashita was terminated as Chief Scientific Officer at TuHURA Biosciences, Inc./NV.
  - Action: terminated
  - Role: Chief Scientific Officer
  source text: the Separation Agreement confirms that Mr. Yamashita’s employment with TuHURA terminated effective December 16, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000095017025065057/0000950170-25-065057-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.